Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Grant | Alive

About siRNAsense

Developer of RNA interference (RNAi) therapeutics. The company develops RNAi drugs within the fields of cancer and neuroscience.

siRNAsense Headquarter Location

Gaustadalleen 21

Oslo, 0349,


47 22 95 81 92

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.